Selected research
Industry Growth & Trends
Global Sarcopenia Supplement Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Sarcopenia Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Sarcopenia Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Sarcopenia Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sarcopenia Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Sarcopenia Supplement market include Zhendong Group, Nestlé, Pfizer, GlaxoSmithKline, Bayer, Usana, H&H, By-health and Blackmores, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Sarcopenia Supplement market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sarcopenia Supplement market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sarcopenia Supplement market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sarcopenia Supplement.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Sarcopenia Supplement market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sarcopenia Supplement Market by Company
Zhendong Group
Nestlé
Pfizer
GlaxoSmithKline
Bayer
Usana
H&H
By-health
Blackmores
Amway
Abbott Laboratories
A&Z Pharmaceutical
Sarcopenia Supplement Segment by Type
Protein Supplement
Calcium Supplement
Other
Sarcopenia Supplement Segment by Application
Online Pharmacies
Retail Pharmacies
Sarcopenia Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sarcopenia Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sarcopenia Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sarcopenia Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Sarcopenia Supplement companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Protein Supplement
- Calcium Supplement
- Other
Applications
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Zhendong Group
- Nestlé
- Pfizer
- GlaxoSmithKline
- Bayer
- Usana
- H&H
- By-health
- Blackmores
- Amway
- Abbott Laboratories
- A&Z Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Sarcopenia Supplement Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Sarcopenia Supplement Market Size by Region (2021-2032)
- 1.4.1 Global Sarcopenia Supplement Market Size by Region (2021-2026)
- 1.4.2 Global Sarcopenia Supplement Market Size by Region (2027-2032)
- 1.5 Key Regions Sarcopenia Supplement Market Size (2021-2032)
- 1.5.1 North America Sarcopenia Supplement Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Sarcopenia Supplement Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Sarcopenia Supplement Market Size Growth Rate (2021-2032)
- 1.5.4 South America Sarcopenia Supplement Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Sarcopenia Supplement Market Size Growth Rate (2021-2032)
2 Sarcopenia Supplement Market by Type
- 2.1 Type Introduction
- 2.1.1 Protein Supplement
- 2.1.2 Calcium Supplement
- 2.1.3 Other
- 2.2 Global Sarcopenia Supplement Market Size by Type
- 2.2.1 Global Sarcopenia Supplement Market Size Overview by Type (2021-2032)
- 2.2.2 Global Sarcopenia Supplement Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Sarcopenia Supplement Market Size Forecasted by Type (2027-2032)
- 2.3 Global Sarcopenia Supplement Market Size by Regions
- 2.3.1 North America Sarcopenia Supplement Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Sarcopenia Supplement Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Sarcopenia Supplement Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Sarcopenia Supplement Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Sarcopenia Supplement Market Size Breakdown by Type (2021-2026)
3 Sarcopenia Supplement Market by Application
- 3.1 Type Introduction
- 3.1.1 Online Pharmacies
- 3.1.2 Retail Pharmacies
- 3.2 Global Sarcopenia Supplement Market Size by Application
- 3.2.1 Global Sarcopenia Supplement Market Size Overview by Application (2021-2032)
- 3.2.2 Global Sarcopenia Supplement Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Sarcopenia Supplement Market Size Forecasted by Application (2027-2032)
- 3.3 Global Sarcopenia Supplement Market Size by Regions
- 3.3.1 North America Sarcopenia Supplement Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Sarcopenia Supplement Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Sarcopenia Supplement Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Sarcopenia Supplement Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Sarcopenia Supplement Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Sarcopenia Supplement Industry Trends
- 4.2 Sarcopenia Supplement Industry Drivers
- 4.3 Sarcopenia Supplement Industry Opportunities and Challenges
- 4.4 Sarcopenia Supplement Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Sarcopenia Supplement Revenue (2021-2026)
- 5.2 Global Sarcopenia Supplement Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Sarcopenia Supplement Key Company Headquarters & Area Served
- 5.4 Global Sarcopenia Supplement Company, Product Type & Application
- 5.5 Global Sarcopenia Supplement Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Sarcopenia Supplement Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Sarcopenia Supplement Players Market Share by Revenue in 2025
- 5.6.3 2025 Sarcopenia Supplement Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Zhendong Group
- 6.1.1 Zhendong Group Company Information
- 6.1.2 Zhendong Group Business Overview
- 6.1.3 Zhendong Group Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Zhendong Group Sarcopenia Supplement Product Portfolio
- 6.1.5 Zhendong Group Recent Developments
- 6.2 Nestlé
- 6.2.1 Nestlé Company Information
- 6.2.2 Nestlé Business Overview
- 6.2.3 Nestlé Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Nestlé Sarcopenia Supplement Product Portfolio
- 6.2.5 Nestlé Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pfizer Sarcopenia Supplement Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 GlaxoSmithKline
- 6.4.1 GlaxoSmithKline Company Information
- 6.4.2 GlaxoSmithKline Business Overview
- 6.4.3 GlaxoSmithKline Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 GlaxoSmithKline Sarcopenia Supplement Product Portfolio
- 6.4.5 GlaxoSmithKline Recent Developments
- 6.5 Bayer
- 6.5.1 Bayer Company Information
- 6.5.2 Bayer Business Overview
- 6.5.3 Bayer Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bayer Sarcopenia Supplement Product Portfolio
- 6.5.5 Bayer Recent Developments
- 6.6 Usana
- 6.6.1 Usana Company Information
- 6.6.2 Usana Business Overview
- 6.6.3 Usana Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Usana Sarcopenia Supplement Product Portfolio
- 6.6.5 Usana Recent Developments
- 6.7 H&H
- 6.7.1 H&H Company Information
- 6.7.2 H&H Business Overview
- 6.7.3 H&H Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 H&H Sarcopenia Supplement Product Portfolio
- 6.7.5 H&H Recent Developments
- 6.8 By-health
- 6.8.1 By-health Company Information
- 6.8.2 By-health Business Overview
- 6.8.3 By-health Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 By-health Sarcopenia Supplement Product Portfolio
- 6.8.5 By-health Recent Developments
- 6.9 Blackmores
- 6.9.1 Blackmores Company Information
- 6.9.2 Blackmores Business Overview
- 6.9.3 Blackmores Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Blackmores Sarcopenia Supplement Product Portfolio
- 6.9.5 Blackmores Recent Developments
- 6.10 Amway
- 6.10.1 Amway Company Information
- 6.10.2 Amway Business Overview
- 6.10.3 Amway Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Amway Sarcopenia Supplement Product Portfolio
- 6.10.5 Amway Recent Developments
- 6.11 Abbott Laboratories
- 6.11.1 Abbott Laboratories Company Information
- 6.11.2 Abbott Laboratories Business Overview
- 6.11.3 Abbott Laboratories Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Abbott Laboratories Sarcopenia Supplement Product Portfolio
- 6.11.5 Abbott Laboratories Recent Developments
- 6.12 A&Z Pharmaceutical
- 6.12.1 A&Z Pharmaceutical Company Information
- 6.12.2 A&Z Pharmaceutical Business Overview
- 6.12.3 A&Z Pharmaceutical Sarcopenia Supplement Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 A&Z Pharmaceutical Sarcopenia Supplement Product Portfolio
- 6.12.5 A&Z Pharmaceutical Recent Developments
7 North America
- 7.1 North America Sarcopenia Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Sarcopenia Supplement Market Size by Country (2021-2026)
- 7.3 North America Sarcopenia Supplement Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Sarcopenia Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Sarcopenia Supplement Market Size by Country (2021-2026)
- 8.3 Europe Sarcopenia Supplement Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Sarcopenia Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Sarcopenia Supplement Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Sarcopenia Supplement Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Sarcopenia Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Sarcopenia Supplement Market Size by Country (2021-2026)
- 10.3 South America Sarcopenia Supplement Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Sarcopenia Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Sarcopenia Supplement Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Sarcopenia Supplement Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst